Vanberra Signal

Healx

Curated by Signal

AI-powered drug discovery platform to treat rare diseases

Overview

AI-powered drug discovery platform to treat rare diseases. The company is pioneering the next generation of drug discovery platforms to bring novel, effective treatments to rare diseases. It has developed a drug pipeline for Fragile X syndrome, Autosomal dominant polycystic kidney disease, Chronic pancreatitis, Facioscapulohumeral muscular dystrophy, and many more.

Key facts

Founded
2014

Contact

Open roles

3 roles
  • Agentic AI Engineer (life sciences)

    Cambridge, England, United Kingdom · On-site · Volunteer

  • Agentic AI Engineer (life sciences)

    Cambridge, England, United Kingdom · On-site · Volunteer

  • Neurofibromatosis Program Manager

    East Hampshire, England, United Kingdom · On-site · Part-time

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Assistive technology for people with impaired executive functions of the brain

    Life Sciences TechnologyExeter, United Kingdom
  • Developer of e therapeutic robot designed to stimulate patients with Dementia, Alzheimer's and others

    Life Sciences TechnologyBagshot, United Kingdom
  • AI based molecular designing software for drug discovery

    Life Sciences TechnologyLondon, United Kingdom

About Healx

What does Healx do?

AI-powered drug discovery platform to treat rare diseases.

Where is Healx headquartered?

Healx is headquartered in Cambridge, United Kingdom.

When was Healx founded?

Healx was founded in 2014.

Which sector is Healx in?

Healx operates in Life Sciences Technology.

Who are Healx's competitors?

Companies similar to Healx include Brain in Hand, Paro, and PostEra.

Is Healx hiring?

Yes. Healx has 3 open roles listed on Vanberra Signal.